Skip to main content
editorial
. 2019 Sep 18;8(5):299–311. doi: 10.1159/000502905

Table 3.

Liver function at TACE refractoriness

Year n Child-Pugh class
A B/C
Ogasawara [23] 2014 122 75% 25%
Arizumi [24] 2014 56 80% 20%
OPTIMIS [25] 2019 636 64% 26%

At the time of TACE refractoriness, liver function has already decreased, and there are many patients who are not good candidates for systemic therapy. TACE refractoriness is too late when considering systemic therapy.